Home › Kanser sa Baga › Minnesota › Duluth
Pag-aaral pangklinika para sa Kanser sa Baga sa Duluth, MN
Isang pag-aaral para sa Kanser sa Baga ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Duluth. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
Nagre-recruitPhase 3
- Essentia Health Cancer Center, Duluth
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Nagre-recruitPhase 3
- Essentia Health Cancer Center, Duluth
Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial
Nagre-recruitPhase 3
- Essentia Health Cancer Center, Duluth
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
- Essentia Health Cancer Center, Duluth
- Essentia Health Saint Mary's Medical Center, Duluth
- Miller-Dwan Hospital, Duluth
- at 2 pa
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
Nagre-recruitPhase 2
- Essentia Health Cancer Center, Duluth
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
Nagre-recruitPhase 2/3
- Essentia Health Cancer Center, Duluth
RMT in Combination With Durvalumab + Chemo in Untreated Adenocarcinoma NSCLC. A Randomized Double Blind Phase II Trial
Nagre-recruitPhase 2
- MNCCTN Essentia Health Duluth, Duluth
Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer
Nagre-recruitPhase 3
- Essentia Health Cancer Center, Duluth
- Essentia Health Saint Mary's Medical Center, Duluth
- Miller-Dwan Hospital, Duluth
- at 1 pa
Integrated Cancer Repository for Cancer Research
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
- Essentia Health - Duluth Clinic, Duluth
- St. Luke's Hospital of Duluth, Duluth
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
Nagre-recruitPhase 2
- Essentia Health Cancer Center, Duluth
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Nagre-recruitObservasyonal na pag-aaral
- Massive Bio SYNERGY-AI site, Duluth
Pag-aaral para sa Kanser sa Baga sa ibang lungsod
- Houston, TX78 pag-aaral
- Boston, MA63 pag-aaral
- New York City, NY60 pag-aaral
- Los Angeles, CA45 pag-aaral
- Chicago, IL43 pag-aaral
- Arlington, VA42 pag-aaral
- Washington, DC41 pag-aaral
- Baltimore, MD41 pag-aaral
- Nashville, TN39 pag-aaral
- St. Louis, MO37 pag-aaral
- Columbus, OH36 pag-aaral
- Philadelphia, PA36 pag-aaral
Iba pang pag-aaral sa Duluth
- Non-Small Cell Lung Cancer14 pag-aaral
- Kanser sa Prostate7 pag-aaral
- Kanser sa Suso7 pag-aaral
- Acute Myeloid Leukemia6 pag-aaral
- Kanser sa Pantog6 pag-aaral
- Colon Cancer6 pag-aaral
- Kanser sa Ovary5 pag-aaral
- Chronic Lymphocytic Leukemia5 pag-aaral
- Kanser ng Endometrium5 pag-aaral
- Kanser sa Tiyan5 pag-aaral
- Rectal Cancer5 pag-aaral
- Kanser sa Esophagus5 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Nob 15, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.